Use of healthcare resources after gestational diabetes mellitus: A longitudinal case–control analysis

Scandinavian Journal of Public Health

Volumn 40, Issue 4, 2012, Pages 385-390

  Anderberg, Eva ^a   Carlsson, Katarina Steen ^b   Berntorp, Kerstin ^a  

^a LUND UNIVERSITY   (Sweden)

^b SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

Author keywords

Costs and cost analysis; healthcare utilisation; longitudinal registry based data; previous gestational diabetes mellitus

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; FEMALE; HEALTH CARE FACILITY; HUMAN; LONGITUDINAL STUDY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PREGNANCY; PREGNANCY DIABETES MELLITUS; STATISTICS; SWEDEN; UTILIZATION REVIEW;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HEALTH FACILITIES; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; SWEDEN;

EID: 84863844179     PISSN: 14034948     EISSN: 16511905     Source Type: Journal    
DOI: 10.1177/1403494812449923     Document Type: Article

References (24)

1. Freinkel N. Josimivich J. Conference Planning Committee, American Diabetes Association Workshop-Conference on Gestational Diabetes: summary and recommendation. Diabetes Care 1980;3(3):499–501.
2. Kim C. Newton K.M. Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25(10):1862–8.
3. Bellamy L. Casas J-P Hingorani A.D. Williams D. Type 2 diabetes mellitus after gestational diabetes: a systemic review and meta-analysis. Lancet 2009;373(9677):1773–9.
4. Anderberg E. Källen K. Berntorp K. Frid A. Åberg A. A simplified oral glucose tolerance test in pregnancy: compliance and results. Acta Obstet Gynecol Scand 2007;86(12):1432–6.
5. Lind T. Phillips PR. Influence of pregnancy on the 75-g OGTT. A prospective multicenter study. The diabetes pregnancy study group of the European association for the study of diabetes. Diabetes Care 1991;40 Suppl 2:8–13.
6. Hunt K.J. Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007;34(2):173–99, vii.
7. Tuomilehto J. Lindström J. Eriksson J.G. Valle T.T. Hämäläinen H. Ilanne-Parikka P. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343–50.
8. Knowler W.C. Barrett-Connor E. Fowler S.E. Hamman R.F. Lachin J.M. Walker E.A. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393–403.
9. Ratner R.E. Christophi C.A. Metzger B.E. Dabelea D. Bennett P.H. Pi-Sunyer X. et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 2008;93(12):4774–9.
10. Åberg A. Jönsson E. Eskilsson I. Landin-Olsson M. Frid A. Predictive factors of developing diabetes mellitus in women with gestational diabetes. Acta Obstet Gynecol Scand 2002;81(1):11–16.
11. Ekelund M. Shaat N. Almgren P. Groop L. Berntorp K. Prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetologia 2010;53(3):452–7.
12. Henriksson F. Agardh C-D Berne C. Bolinder J. Lönnqvist F. Stenström P. et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med 2000;248(5):387–96.
13. Jönsson B. Revealing the cost of type II diabetes in Europe. Diabetologia 2002;45(7):S5–S12.
14. Ettaro L. Songer T.J. Zhang P. Engelgau MM. Cost-of-illness studies in diabetes mellitus. Pharmaco Economics 2004;22(3):149–64.
15. Gerdtham U.G. Clarke P. Hayes A. Gudbjornsdottir S. Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data. Pharmaco Economics 2009;27(1):81–90.
16. Bolin K. Gip C. Mörk A.C. Lindgren B. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005 – a register-based approach. Diabet Med 2009;26(9):928–34.
17. Altman D. Practical statistics for medical research. London: Chapman & Hill, 1991.
18. Stata Corp. Stata: release 11. statistical software. College Station, TX: Stata Corp, 2009.
19. Brown J.B. Nichols G.A. Glauber H.S. Bakst AW. Type 2 diabetes: incremental medical care cost during the first 8 years after diagnosis. Diabetes Care 1999;22(7):1116–24.
20. Jonsson P.M. Marké L-Å Nyström L. Wall S. Östman J. Excess costs of medical care 1 and 8 years after diagnosis of diabetes: estimate from young and middle-aged incidence cohorts in Sweden. Diabetes Res Clin Pract 2000;50(1):35–47.
21. Ringborg A. Martinell M. Stålhammar J. Yin D. Lindgren P. Resource use and costs of type 2 diabetes in Sweden – estimates from population-based register data. Int J Clin Pract 2008;62(5):708–16.
22. Clarke P. Gray A. Legood R. Briggs A. Holman R. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study no. 65). Diabet Med 2003;20(6):442–50.
23. Norlund A. Appelqvist J. Bitzén P-O Nyberg P. Schertzén B. Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Int Med 2001;250(1):57–65.
24. Brandle M. Zhou H. Smith B.R. Marriott D. Burke R. Tabaei B.P. et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003:26(8):2300–4.